LCN2 and endometrial cancer: Following the analysis of all the hitherto recognized unfavorable prognostic factors of endometrial cancer, we determined that the NGAL levels were higher in patients with higher stage of endometrial cancer (FIGO III and IV versus FIGO I and II) (p = 0.001) as well as in patients with poorly differentiated G3 tumors as compared to patients with well-differentiated G1 tumors (p = 0.003).